≡

CLIA Kit for Erythroferrone (ERFE)

FAM132B; C1QTNF15; CTRP15; Myonectin; Family With Sequence Similarity 132, Member B; Complement C1q tumor necrosis factor-related protein 15

Specificity

This assay has high sensitivity and excellent specificity for detection of Erythroferrone (ERFE).
No significant cross-reactivity or interference between Erythroferrone (ERFE) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Erythroferrone (ERFE) and the recovery rates were calculated by comparing the measured value to the expected amount of Erythroferrone (ERFE) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 84-101 89
EDTA plasma(n=5) 95-104 101
heparin plasma(n=5) 89-101 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Erythroferrone (ERFE) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Erythroferrone (ERFE) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Erythroferrone (ERFE) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-94% 86-102% 84-101% 83-103%
EDTA plasma(n=5) 99-105% 88-102% 91-99% 81-97%
heparin plasma(n=5) 94-102% 93-101% 98-105% 79-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
Substrate A 1×10mL Substrate B 1×2mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
BRITISH JOURNAL OF HAEMATOLOGY Disordered serum erythroferrone and hepcidin levels as indicators of the spontaneous abortion occurrence during early pregnancy in humans Pubmed: 32866306
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPU540Hu01 Recombinant Erythroferrone (ERFE) Positive Control; Immunogen; SDS-PAGE; WB.
RPU540Hu02 Recombinant Erythroferrone (ERFE) Positive Control; Immunogen; SDS-PAGE; WB.
PAU540Hu01 Polyclonal Antibody to Erythroferrone (ERFE) WB; IHC; ICC; IP.
SEU540Hu ELISA Kit for Erythroferrone (ERFE) Enzyme-linked immunosorbent assay for Antigen Detection.
SCU540Hu CLIA Kit for Erythroferrone (ERFE) Chemiluminescent immunoassay for Antigen Detection.
LMU540Hu Multiplex Assay Kit for Erythroferrone (ERFE) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.